Bookmark

Add to MyYahoo RSS

Advanced Transit Dynamics News

News on Advanced Transit Dynamics (Ticker: JNJ) continually updated from thousands of sources around the net.

54 min ago | Entrepreneur Magazine

What Does a Multibillion-Dollar Corporation Want With Crowdfunding?

As of this morning, consumer products giant Johnson & Johnson was worth almost $300 billion.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

5 hrs ago | The Jersey Journal

Man found dead near New Brunswick train station had belt around neck, police say

NEW BRUNSWICK - A 36-year-old man whose decomposed body was found near the city train station a week after he was reported missing apparently committed suicide near the station, according to a recently released police report.

Comment?

Related Topix: Suicide, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Thu Jul 31, 2014

PhysOrg Weblog

Johnson & Johnson pulls hysterectomy tool tied to cancer risk from market

The largest maker of a surgical tool that has shown an increased risk of spreading undetected cancers in women has said it will withdraw its device from the market.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

NEWS.com.au

Cinema verite pioneer Robert Drew dies

JOHNSON & Johnson is pulling its fibroid treatment devices worldwide following concerns it could spread cancer to other parts of the body.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

Medical News

Codman Neuro introduces new ENVOY Guiding Catheters for neurovascular procedures

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the launch of the ENVOY DA XB Distal Access Guiding Catheter and the 7F ENVOY Guiding Catheter for neurovascular procedures.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Business Journal

Johnson & Johnson recalls power morcellators

A surgical device maker on Wednesday issued a voluntary worldwide recall of its products because of the risk of spreading undetected cancer.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Wed Jul 30, 2014

Reuters

J&J seeks return of device seen as possibly raising cancer risk

Johnson & Johnson said on Wednesday it plans to ask doctors to return its power morcellators, a controversial surgical device that may inadvertently spread cancer in women being treated for uterine growths called fibroids.

Comment?

Related Topix: Food, J and J Snack Foods, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Business Journal

Dendreon appoints retired Johnson & Johnson exec as new CEO

Seattle cancer drug-maker Dendreon has named 71-year-old retired biotech executive W. Thomas Amick as the company's new CEO.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Dendreon, VisionCare Ophthalmic Technologies, Startups

BioResearch Online

J&J And Organovo Link For 3D-Printing Drug Discovery

Johnson & Johnson company Janssen Research and Development announced that it is has entered into collaboration with bioprinting firm Organovo to investigate 3D printing of living tissue for drug discovery and research.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Tue Jul 29, 2014

ZDNet

IBM board adds Johnson & Johnson CEO, former Royal Dutch Shell CEO

Closing out a month that included a landmark deal with Apple, IBM is boosting its board of directors with two new additions who are seasoned chief executives.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Sun Jul 27, 2014

The Telegraph

High valuations put on older generics

Mumbai, July 27: GlaxoSmithKline Plc is likely to receive a good response if it indeed puts up its older but off-patented drugs for sale, given the massive gain Bafna Pharma made from Raricap.

Comment?

Related Topix: Biotech, Dr Reddys Laboratories, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Tue Jul 22, 2014

Business Journal

Johnson & Johnson board approved $5B stock buyback plan

Johnson & Johnson's board of directors approved a plan for the New Jersey health-care company to repurchase up to $5 billion of its common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Jersey Journal

Johnson & Johnson volunteers support Buck Garden in Far Hills

Johnson & Johnson 'Day of Caring' volunteers descended upon Somerset County Park Commission Leonard J. Buck Garden at 11 Layton Road in Far Hills.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Far Hills, NJ, Startups

Thu Jul 17, 2014

BioSpace

Johnson & Johnson Spinout Zosano Pharma, Inc. Sets Terms For $70 Million IPO

Zosano Pharma, a biotech developing a transdermal delivery system to treat osteoporosis, announced terms for its IPO on Wednesday.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, LOC-AID Technologies, Conor Medsystems

Wed Jul 16, 2014

Daily Kos

Three Documentary Films All Progressives Should See, Learn & Memorize

As part of another diary I brought up several excellent sources of Truth, Reality and Knowledge and today I re-post that information purely for it's own sake because I truly believe - it's worth the effort and benefit that it may impart to all those who are willing to listen and capable of comprehending the message.

Comment?

Related Topix: Action Movies, Comedy Movies, Thriller, The One, Science Fiction Movies, Aria Systems, LOC-AID Technologies, George Bush, Netflix, Startups

Wall St. Cheat Sheet

Does Johnson & Johnson Belong in Your Portfolio?

The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Tue Jul 15, 2014

Reuters

UPDATE 3-J&J beats forecasts, helped by new hepatitis C drug

Johnson & Johnson reported higher-than-expected quarterly results on sizzling sales of its new Olysio treatment for hepatitis C, but company officials cautioned the pill will lose steam later this year as newer rivals come to market.

Comment?

Related Topix: Food, J and J Snack Foods, Hepatitis, Medicine, Health, Johnson & Johnson, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Customer Interaction Solutions

Medivir: Continued strong market uptake for OLYSIO during the second quarter 2014

Medivir AB announces that the global second quarter net sales of Olysio amounted to 831 MUSD, of which 725 MUSD were sales in the USA.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, LOC-AID Technologies

TheStreet.com

Johnson & Johnson (JNJ) Falls Despite Earnings Beat, Strong Olysio Sales

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Modesto Bee

Stock futures edge up following mixed retail data

Stock futures edged higher Tuesday as investors digested mixed U.S. retail sales data and several corporate earnings reports.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••